Genetic polymorphisms of the protein tyrosine phosphatase non-receptor 22 (PTPN22) are reported to be involved in atherosclerosis and played a role in the immune response involved in the pathogenesis of CAD [43,44]. This evidence concerns the gene PTPN22 and atherosclerosis.